Bionomics Limited operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Bionomics Limited with three other companies in this sector in Australia: Benitec Biopharma Limited (2018 sales of 4.62 million Australian Dollars [US$3.31 million] ), Oncosil Medical Ltd (4.59 million Australian Dollars [US$3.29 million] ), and Starpharma Holdings Limited (4.96 million Australian Dollars [US$3.56 million] of which 100% was Dendritic).

Sales Analysis. Sales fell dramatically in 2018: During the year ended June of 2018, sales at Bionomics Limited were A$3.95 million (US$2.84 million). This is a sharp decrease of 78.7% versus 2017, when the company's sales were A$18.61 million. The sales level in 2018 was fairly close to the level five years ago: in 2013, Bionomics Limited had sales of A$3.72 million. Contributing to the drop in overall sales was the 92.7% decline in Drug Discovery and Development, from A$16.42 million to A$1.20 million. . However, these declines were partially offset by the increase in sales of Contract Services (up 23.2% to A$7.09 million) and Corporate (up 27.6% to A$200,532.00 ) .